Evolving role of prostate-specific membrane antigen-positron emission tomography in metastatic hormone-sensitive prostate cancer: more questions than answers?
Name:
35439030.pdf
Size:
188.6Kb
Format:
PDF
Description:
Identified with Open Access button
Authors
Hussain, M.Carducci, M. A.
Clarke, Noel W
Fenton, S. E.
Fizazi, K.
Gillessen, S.
Jacene, H.
Morris, M. J.
Saad, F.
Sartor, O.
Taplin, M. E.
Vapiwala, N.
Williams, S.
Sweeney, C.
Affiliation
Robert H Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, ILIssue Date
2022
Metadata
Show full item recordCitation
Hussain M, Carducci MA, Clarke N, Fenton SE, Fizazi K, Gillessen S, et al. Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2022.Journal
Journal of Clinical OncologyDOI
10.1200/jco.22.00208PubMed ID
35439030Additional Links
https://dx.doi.org/10.1200/jco.22.00208Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1200/jco.22.00208
Scopus Count
Collections
Related articles
- Role of Prostate-Specific Membrane Antigen PET in Metastatic Prostate Cancer: We Have the Answers.
- Authors: Pomykala KL, Herrmann K, Padhani AR, Hofman MS, Lalumera E, Fanti S
- Issue date: 2022 Oct
- Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging.
- Authors: Ferraro DA, Burger IA
- Issue date: 2020 Feb
- [Prostate-specific membrane antigen positron emission tomography (PSMA PET) for urologists-when and which tracer?].
- Authors: Berliner C, Kesch C, Fendler WP, Eiber M, Maurer T
- Issue date: 2022 Apr
- Impact of a Novel Molecular Imaging Modality, Prostate-Specific Membrane Antigen Positron Emission Tomography, on the Management of Prostate Cancer.
- Authors: Patel NA, Reiter RE
- Issue date: 2022 May 1
- Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.
- Authors: Alvim R, Nagar K, Das S, Lebdai S, Wong N, Somma A, Hughes C, Thomas J, Monette S, Scherz A, Kim K, Grimm J, Coleman JA
- Issue date: 2021 Mar